September/October 2012

Biopharma Asia

September/October 2012 | Volume 1 Issue 1


Launching a Global Product into the Japanese Market

By: Takao Ishida, Head of Quality and Security Biogen Idec Japan Ltd


Aligning Regulations with the Development of Crucial Vaccines to Address Asia’s Vaccine ...

By: Der-Yuan Wang, Section Chief FDA Taiwan


Quality by Design – Worth the effort?

By: Zoher Sihorwala, Vice President And Global Head Of Regulatory Affairs Dr Reddy’s Lab...


Enabling Formulation Approaches for Poorly Soluble Compounds in Early Development

By: Keith Horspool, Vice President Pharmaceutical Development; Chandan Bhugra, Principal S...


Label-free cell-based assay technologies in GPCR drug discovery

By: Hong Xin, Principal Scientist. Janssen Research And Development


Stem Cells and Regenerative Medicine in Asia, drug development, supporting cell therapy, A...

By: Mahendra Rao, Head of Center for Regenerative Medicine. NIH


Leveraging the benefits offered by HME over traditional Processing Techniques to enhance t...

By: Sanju Dhawan, Manager In The Integrated Product Development Organisation; Raviraj Pill...


The Disposable Facility and Single-Use Technology – a Solution or a Revolution?

Dedicated to Prof. Dr. Rolf G Werner on the occasion of his 66th birthday. By: Joachim Wal...